The Journal of antimicrobial chemotherapyHumansCOVID-19Hematologic NeoplasmsSARS-CoV-2Antiviral Agents
Strategies for mitigating severe COVID-19 in patients with haematological malignancy during the omicron era.
Keiji Okinaka, Joshua T Schiffer
Published: 202610.1093/jac/dkaf489
Abstract
Despite a decrease in disease severity since the emergence of the severe acute respiratory syndrome coronavirus 2 Omicron variant, coronavirus disease-2019 (COVID-19) continues to pose a significant threat to patients with haematological malignancies…
Preview only. Read the full abstract at the source